Replay

Replay Therapeutics

This biotech company develops genome writing and delivery platforms to provide genetic medicines for patients with rare skin, eye and haematological diseases.

Ensoma

This company develops in vivo genomic medicines and vector delivery platforms to engineer blood and immune cells for patients with genetic diseases and cancer.

Code Bio

This company develops non-viral genetic medicine delivery platforms and therapies for patients with rare and prevalent genetic diseases.

Transforming cells into cures

This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.

LogicBio

This company develops gene editing and delivery platforms to provide one-time treatments for patients with serious, early-onset rare genetic diseases.

Tessera

The company develops genome engineering platforms to write therapeutic DNA sequences into cells for clinicians and researchers treating genetic diseases.

Codebreaker

This company develops a synthetic biology platform generating causal genomics data to help clinicians and researchers interpret genetic variants for disease diagnosis.

Metagenomi

Metagenomi develops genome editing tools and genetic medicines for patients with genetic mutations.